Netzsch removes risk from process scaling

Published: 16-Nov-2010
Manufacturing

LabStar multi-functional mill can be scaled-up to comparable production machines

Netzsch removes risk from process scaling
Netzsch Mastermix, part of Netzsch Group’s grinding and dispersing business unit, has developed the LabStar Pilot/Laboratory bead mill, which is the smallest grinding mill in its portfolio.

The company says the LabStar can be directly scaled up to its larger cousins in the Netzsch bead mill range.

Configurable as a Zeta peg milling system or as a TriNex disc milling system, LabStar replicates all of the possible combinations and applications that are encountered by full-size production mills.

Available in a range of materials, and ATEX certified, the Lichfield, UK-based firm says there is a configuration to match any production situation that needs to be accurately defined at a pilot scale.

  • Companies:
  • Netzsch Group
See more

You may also like

Manufacturing
Fine granulation and greater efficiency

Fine granulation and greater efficiency

Read more
Until recently, achieving fine granulation meant lower productivity. Andy James, at Netzsch Mastermix, argues that with high density bed jet mills this is no longer the case

Trending Articles

  1. Sterling Pharma Solutions doubles ADC manufacturing capacity at Deeside with new GMP suite The multi-million-pound expansion adds a 1400 sqft Grade C cleanroom, OEB5 containment handling and a 3400 sqft analytical laboratory — extending Sterling's bioconjugation capability from development through to Phase III and commercial scale
  2. FDA inspection readiness: Preparing for surveillance and pre-approval inspections Preparing pharma and biotech teams for continuous FDA inspection readiness, mock inspections and proactive regulatory risk management
  3. Hovione to install first ConsiGma CDC Flex continuous tableting line in US The CDMO is investing $35m in a next-generation continuous tableting line at its 89 Twin Rivers facility in New Jersey, creating an integrated US pathway from spray-dried amorphous solid dispersions to commercial tablet production
  4. SCHOTT Pharma makes decarbonisation measurable Validated carbon footprint tool supports informed Scope 3 reduction decisions for pharmaceutical packaging
  5. FDA Form 483 explained: responding to findings and managing regulatory risk Explore what a Form FDA 483 means, how to respond within 15 business days, assess patient risk, address observations and understand how FDA evaluates responses and inspection outcomes

You may also like

Manufacturing
Fine granulation and greater efficiency

Fine granulation and greater efficiency

Until recently, achieving fine granulation meant lower productivity. Andy James, at Netzsch Mastermix, argues that with high density bed jet mills this is no longer the case
Manufacturing
Your checkweigher is now a GMP data system — are you treating it like one?

Your checkweigher is now a GMP data system — are you treating it like one?

The weighing mechanism may be familiar. The regulatory expectations around the data it creates are becoming much harder to ignore.
Manufacturing
Step into cognitive manufacturing: Welcoming you to Booth S-1720

Step into cognitive manufacturing: Welcoming you to Booth S-1720

At Pack Expo 2026, IMA Group will showcase its latest innovations in processing, packaging, end-of-line, automation, as well as digital solutions and customer services across the Pharmaceutical, Med-Tech, Food, Personal Care, E-Commerce and Labeling industries
Manufacturing
Xelia and Hisun sign strategic global multiple-API partnership

Xelia and Hisun sign strategic global multiple-API partnership

Long-standing joint venture partners expand collaboration, moving beyond anti-infective APIs into diversified therapeutic areas, including cardiovascular and oncology
Manufacturing
Patented device reinvents Solid Phase Extraction

Patented device reinvents Solid Phase Extraction

Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition
Manufacturing
Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility

Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility

The €29m ATLab site will target up to 10,000 doses annually and its two-hour proximity to major European airports meets the critical 24-hour production-to-administration window imposed by lead-212's 10.6-hour half-life
Manufacturing
Lonza advances aseptic spray drying for high-dose biologics

Lonza advances aseptic spray drying for high-dose biologics

This new technology platform addresses stability, concentration, and delivery challenges in biologics, including new modalities
Subscribe now